OptimizeRx: Q2 Earnings Insights

Shares of OptimizeRx OPRX moved lower in after-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share were up 400.00% year over year to $0.10, which beat the estimate of $0.07.

Revenue of $13,626,000 higher by 55.14% year over year, which beat the estimate of $12,450,000.

Outlook

Earnings guidance hasn't been issued by the company for now.

OptimizeRx hasn't issued any revenue guidance for the time being.

Details Of The Call

Date: Aug 04, 2021

Time: 04:30 PM

ET Webcast URL: https://viavid.webcasts.com/starthere.jsp?ei=1484054&tp_key=7eacf33079

Price Action

Company's 52-week high was at $63.98

Company's 52-week low was at $13.97

Price action over last quarter: Up 10.73%

Company Description

OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution support patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!